Experienced in Iridogoniodysgenesis Type 1

Dr. Stanley O. Stringam

Internal Medicine
St Lukes Clinic-Treasure Valley LLC
3165 E Greenhurst Rd, 
Nampa, ID 
Accepting New Patients
Experienced in Iridogoniodysgenesis Type 1
St Lukes Clinic-Treasure Valley LLC
3165 E Greenhurst Rd, 
Nampa, ID 
OverviewInsuranceLocationsClinical Research

Overview

Stanley Stringam is an Internal Medicine provider in Nampa, Idaho. Dr. Stringam and is rated as an Experienced provider by MediFind in the treatment of Iridogoniodysgenesis Type 1. His top areas of expertise are Osteomyelitis in Children, Type 2 Diabetes (T2D), Familial Combined Hyperlipidemia, and Xanthoma. Dr. Stringam is currently accepting new patients.

His clinical research consists of participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in ID
Hospital Affiliations
St Luke's Nampa Medical Center
Saint Alphonsus Regional Medical Center
St Luke's Regional Medical Center
Languages Spoken
English
French
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  PacificSource
  •  Moda Health
  •  Health Net
  •  Humana

Locations

ST LUKES CLINIC-TREASURE VALLEY LLC
3165 E Greenhurst Rd, Nampa, ID 83686

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial
Similar Doctors
Experienced in Iridogoniodysgenesis Type 1
Dr. Susan L. Blough
Internal Medicine
Experienced in Iridogoniodysgenesis Type 1
Dr. Susan L. Blough
Internal Medicine
701 E Parkcenter Blvd, 
Boise, ID 
 (17.4 mi)
208-381-6400
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Susan Blough is an Internal Medicine provider in Boise, Idaho. Dr. Blough and is rated as an Experienced provider by MediFind in the treatment of Iridogoniodysgenesis Type 1. Her top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Benign Paroxysmal Positional Vertigo. Dr. Blough is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile